Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
Robert Huddart(Institute of Cancer Research), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), A. Norman(Royal Marsden NHS Foundation Trust), Maryam Shahidi(Royal Marsden NHS Foundation Trust), A. Horwich(Institute of Cancer Research), J. Nicholls(Royal Marsden NHS Foundation Trust), Doris D. Coward(Institute for Women's Policy Research)
Cited by 548
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
|European Journal of Cancer|2005|576
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|280